Clinical Research
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Apr 28, 2008; 14(16): 2511-2516
Published online Apr 28, 2008. doi: 10.3748/wjg.14.2511
Table 1 Characteristics of the patients with ulcerative colitis
Patient No.AgeSexDisease extentClinical patternDisease duration (yr)Disease severityTreatment
5-ASA (mesalazine)(SASP)Steroid (predonine)
123MaleTotalRelapsing6Moderate+
238FemaleTotalRelapsing2Moderate++
332MaleTotalRelapsing2Moderate++
436FemaleProctitisRelapsing15Mild+
523MaleTotalFirst3Moderate+
620MaleTotalRelapsing2Moderate++
725MaleTotalFirst0.5Moderate+
842MaleLeft-sidedChronic7Moderate++
936MaleLeft-sidedRelapsing14Moderate++

  • Citation: Imaoka A, Shima T, Kato K, Mizuno S, Uehara T, Matsumoto S, Setoyama H, Hara T, Umesaki Y. Anti-inflammatory activity of probiotic Bifidobacterium: Enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J Gastroenterol 2008; 14(16): 2511-2516
  • URL: https://www.wjgnet.com/1007-9327/full/v14/i16/2511.htm
  • DOI: https://dx.doi.org/10.3748/wjg.14.2511